Correlation between gamma index passing rate and clinical dosimetric difference for pre-treatment 2D and 3D volumetric modulated arc therapy dosimetric verification

British Journal of Radiology

Volumn 88, Issue 1047, 2015, Pages

  Jin, X ^a   Yan, H ^a   Han, C ^a   Zhou, Y ^a   Yi, J ^a   Xie, Congying ^a  

^a THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AREA UNDER THE CURVE; ARTICLE; CANCER THERAPY; CLINICAL ARTICLE; COMPUTER PROGRAM; DOSE VOLUME HISTOGRAM; DOSIMETER; DOSIMETRY; ESOPHAGUS CANCER; GAMMA INDEX PASSING RATE; HISTOGRAM; HUMAN; MEASUREMENT ERROR; NASOPHARYNX CANCER; QUALITY CONTROL; RADIOLOGICAL PARAMETERS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY ANALYSIS; VOLUMETRIC MODULATED ARC THERAPY; VOLUMETRY; AGED; COMPARATIVE STUDY; COMPUTER ASSISTED RADIOTHERAPY; FEMALE; GAMMA RADIATION; INTENSITY MODULATED RADIATION THERAPY; MALE; NASOPHARYNGEAL NEOPLASMS; PROCEDURES; RADIATION DOSE; RADIOGRAPHY; RADIOMETRY; THERAPEUTIC USE;

AGED; FEMALE; GAMMA RAYS; HUMANS; MALE; NASOPHARYNGEAL NEOPLASMS; RADIOMETRY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; SOFTWARE;

EID: 84923463366     PISSN: 00071285     EISSN: 1748880X     Source Type: Journal    
DOI: 10.1259/bjr.20140577     Document Type: Article

References (24)

1. Bedford JL, Nordmark Hansen V, McNair HA, Aitken AH, Brock JE, Warrington AP, et al. Treatment of lung cancer using volumetric modulated arc therapy and image guidance: A case study. Acta Oncol 2008; 47: 1438-43. doi: 10.1080/02841860802282778
2. Otto K. Volumetric modulated arc therapy: IMRT in a single gantry arc. Med Phys 2008; 35: 310-17
3. Feygelman V, Zhang G, Stevens C. Initial dosimetric evaluation of SmartArc-A novel VMAT treatment planning module implemented in a multi-vendor delivery chain. J Appl Clin Med Phys 2010; 11: 3169
4. Yu CX, Tang G. Intensity-modulated arc therapy: Principles, technologies and clinical implementation. Phys Med Biol 2011; 56: R31-54. doi: 10.1088/0031-9155/56/5/R01
5. Pallotta S, Marazzo L, Bucciolini M. Design and implementation of a water phantom for IMRT, arc therapy, and tomotherapy dose distribution measurements. Med Phys 2007; 34: 3724-31
6. Létourneau D, Publicover J, Kozelka J, Moseley DJ, Jaffray DA. Novel dosimetric phantom for quality assurance of volumetric modulated arc therapy. Med Phys 2009; 36: 1813-21
7. Gagne IM, Ansbacher W, Zavgorodni S, Popescu C, Beckham WA. A Monte Carlo evaluation of RapidArc dose calculations for oropharynx radiotherapy. Phys Med Biol 2008; 53: 7167-85. doi: 10.1088/0031-9155/53/24/011
8. Korreman S, Medin J, Kjaer-Kristoffersen F. Dosimetric verification of RapidArc treatment delivery. Acta Oncol 2009; 48: 185-91. doi: 10.1080/02841860802287116
9. Verbakel WF, Cuijpers JP, Hoffmans D, Bieker M, Slotman BJ, Senan S. Volumetric intensity-modulated arc therapy vs. conventional IMRT in head-and-neck cancer: A comparative planning and dosimetric study. Int J Radiat Oncol Biol Phys 2009; 74: 252-9. doi: 10.1016/j.ijrobp.2008.12.033
10. Rao M, Yang W, Chen F, Sheng K, Ye J, Mehta V, et al. Comparison of Elekta VMAT with helical tomotherapy and fixed field IMRT: Plan quality, delivery efficiency and accuracy. Med Phys 2010; 37: 1350-9
11. Ezzell GA, Burmeister JW, Dogan N, LoSasso TJ, Mechalakos JG, Mihailidis D, et al. IMRT commissioning: Multiple institution planning and dosimetry comparisons, a report from AAPM Task Group 119. Med Phys 2009; 36: 5359-73
12. O'Daniel J, Das S, Wu QJ, Yin FF. Volumetric-modulated arc therapy: Effective and efficient end-to-end patient-specific quality assurance. Int J Radiat Oncol Biol Phys 2012; 82: 1567-74. doi: 10.1016/j. ijrobp.2011.01.018
13. Schreibmann E, Dhabaan A, Elder E, Fox T. Patient-specific quality assurance method for VMAT treatment delivery. Med Phys 2009; 36: 4530-5
14. Zhen H, Nelms BE, Tome WA. Moving from gamma passing rates to patient DVH-based QA metrics in pretreatment dose QA. Med Phys 2011; 38: 5477-89. doi: 10.1118/1.3633904
15. Stasi M, Bresciani S, Miranti A, Maggio A, Sapino V, Gabriele P. Pretreatment patientspecific IMRT quality assurance: A correlation study between gamma index and patient clinical dose volume histogram. Med Phys 2012; 39: 7626-34. doi: 10.1118/1.4767763
16. Jin X, Yi J, Zhou Y, Yan H, Han C, Xie C. Comparison of whole field simultaneous integrated boost VMAT and IMRT in the treatment of nasopharyngeal cancer. Med Dosim 2013; 38: 418-23. doi: 10.1016/j. meddos.2013.05.004
17. Jin X, Yi J, Zhou Y, Yan H, Han C, Xie C. CRT combined with a sequential VMAT boost in the treatment of upper thoracic esophageal cancer. J Appl Clin Med Phys 2013; 14: 153-61. doi: 10.1120/jacmp. v14i5.4325
18. Yan G, Lu B, Kozelka J, Liu C, Li JG. Calibration of a novel four-dimensional diode array. Med Phys 2010; 37: 108-15
19. Nelms BE, Opp D, Robinson J, Wolf TK, Zhang G, Moros E, et al. VMAT QA: Measurement-guided 4D dose reconstruction on a patient. Med Phys 2012; 39: 4228-38. doi: 10.1118/1.4729709
20. Nelms BE, Simon WE. U.S. patent no. 7945022. 2011
21. Bailey DW, Nelms BE, Attwood K, Kumaraswamy L, Podgorsak M. Statistical variability and confidence intervals for planar dose QA pass rates. Med Phys 2011; 38: 6053-64. doi: 10.1118/1.3651695
22. Nelms BE, Zhen H, Tomé WA. Per-beam, plannar IMRT QA passing rates do not predict clinically relevant patient dose errors. Med Phys 2011; 38: 1037-44
23. Feygelman V, Opp D, Zhang G, Stevens C, Nelms B. Experimental verification of the planned dose perturbation algorithm in an anthropomorphic phantom. J Phys Conf Ser 2013; 444: 012047
24. Carrasco P, Jornet N, Latorre A, Eudaldo T, Ruiz A. Ribas M. 3D DVH-based metric analysis versus per-beam planar analysis in IMRT pretreatment verification. Med Phys 2012; 39: 5040-9. doi: 10.1118/1.4736949